Association of METTL14 expression with prognosis and immunotherapy in breast cancer

Junbo Hu; Min Zhang; Yanju Lu; Zhen Wei; Lindan Dong; Yong Li; Honglin Yan; Na Tang

doi:10.21037/tcr-2025-1331

January 1, 2026Translational Cancer ResearchOpen Access

Association of METTL14 expression with prognosis and immunotherapy in breast cancer

View Full Paper

Ask AI

Bookmark

Share

Key Points

METTL14 expression is linked to breast cancer prognosis, indicating its clinical relevance.
A predictive value associated with METTL14 suggests that it could serve as a biomarker for treatment outcomes.
Observational analysis indicates that METTL14 may be a promising target in immunotherapy strategies for breast cancer.
Further investigation is necessary to validate METTL14's role as a therapeutic target due to its potential implications in treatment.

Implication

This analysis uncovers the role of METTL14 as a biomarker for prognosis in breast cancer, suggesting its potential for immunotherapy.

Abstract

METTL14 demonstrates significant predictive value regarding prognosis in BC. The METTL14 has the potential to serve as a predictive biomarker and a promising target for immunotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hu et al. (2026) studied this question.

synapsesocial.com/papers/69a75d7fc6e9836116a279bc https://doi.org/10.21037/tcr-2025-1331

View Full Paper

Ask AI

Bookmark

Share

Association of METTL14 expression with prognosis and immunotherapy in breast cancer

Key Points

Implication

Abstract

Discussion

Cite This Study

Association of METTL14 expression with prognosis and immunotherapy in breast cancer

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More from Translational Cancer Research

Keep reading

More from Translational Cancer Research